In recent trading session, Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) saw 26.53 million shares changing hands at last check today with its beta currently measuring 2.08. Company’s recent per share price level of $0.39 trading at -$0.04 or -8.79% at last check today assigns it a market valuation of $73.30M. That most recent trading price of TNXP’s stock is at a discount of -3100.0% from its 52-week high price of $12.48 and is indicating a premium of 69.23% from its 52-week low price of $0.12. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 140.31 million shares which gives us an average trading volume of 125.82 million if we extend that period to 3-months.
For Tonix Pharmaceuticals Holding Corp (TNXP), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 4 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) trade information
Upright in the red during last session for losing -8.79%, in the last five days TNXP remained trading in the green while hitting it’s week-highest on Tuesday, 01/28/25 when the stock touched $0.39 price level, adding 33.1% to its value on the day. Tonix Pharmaceuticals Holding Corp’s shares saw a change of 18.92% in year-to-date performance and have moved 19.76% in past 5-day. Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) showed a performance of 16.17% in past 30-days. Number of shares sold short was 7.67 million shares which calculate 0.35 days to cover the short interests.
Tonix Pharmaceuticals Holding Corp (TNXP) estimates and forecasts
Statistics highlight that Tonix Pharmaceuticals Holding Corp is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -30.61% of value to its shares in past 6 months, showing an annual growth rate of 91.94% while that of industry is 17.40. Apart from that, the company came raising its revenue forecast for fiscal year 2025.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 79.31% during past 5 years.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)’s Major holders
Insiders are in possession of 0.17% of company’s total shares while institution are holding 0.23 percent of that, with stock having share float percentage of 0.23%. Investors also watch the number of corporate investors in a company very closely, which is 0.23% institutions for Tonix Pharmaceuticals Holding Corp that are currently holding shares of the company.
On the other hand, Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Oct 31, 2024, the former fund manager was holding 113.13 shares of worth $44144.0 or 0.06% of the total outstanding shares. The later fund manager was in possession of 7.3 shares on Sep 30, 2024, making its stake of worth around $2848.0 in the company or a holder of 0.00% of company’s stock.
